BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 28710214)

  • 1. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y; Liu Y; Zou X; Chen W; Ling L
    BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
    Zhang L; Zhang D; Chen W; Zou X; Ling L
    PLoS One; 2013; 8(10):e76931. PubMed ID: 24116185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Related factors and interaction on HIV/HCV co-infection of patients access to methadone maintenance treatment].
    Yao T; Feng D; Pan MH; Cheng YP; Li CX; Wang J; Feng YL; Shi J; Su T; Chen Q; Shi S; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):631-635. PubMed ID: 29860807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan].
    Pu L; Su Y; Wang G; Bai J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):829-31. PubMed ID: 26714537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study.
    Zou X; Xu Y; Chen W; Xia Y; Liu Y; Gong C; Ling L
    Subst Abuse Treat Prev Policy; 2018 Jan; 13(1):1. PubMed ID: 29321039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.
    Zou X; Ling L; Zhang L
    BMJ Open; 2015 Aug; 5(8):e008162. PubMed ID: 26297365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial distribution of HIV, HCV, and co-infections among drug users in the southwestern border areas of China (2004-2014): a cohort study of a national methadone maintenance treatment program.
    Li M; Li R; Shen Z; Li C; Liang N; Peng Z; Huang W; He C; Zhong F; Tang X; Lan G
    BMC Public Health; 2017 Sep; 17(1):759. PubMed ID: 28962612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China.
    Xia YH; McLaughlin MM; Chen W; Ling L; Tucker JD
    PLoS One; 2013; 8(6):e66787. PubMed ID: 23818964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infections.
    Xia YH; Chen W; Tucker JD; Wang C; Ling L
    BMC Public Health; 2013 Sep; 13():899. PubMed ID: 24079351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    Zhuang X; Wang Y; Chow EP; Liang Y; Wilson DP; Zhang L
    Drug Alcohol Depend; 2012 Dec; 126(3):286-95. PubMed ID: 22726912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.
    Miller CL; Wood E; Spittal PM; Li K; Frankish JC; Braitstein P; Montaner JS; Schechter MT
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):743-9. PubMed ID: 15167294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.
    Zhang JY; Li ZB; Zhang L; Wang J; Huang LP; Zhan GL; Li Z; Du J; Zhao M
    BMC Infect Dis; 2019 Sep; 19(1):774. PubMed ID: 31488064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A cross-sectional survey of receiving no methadone maintenance treatment in HIV infected injecting drug users in Dehong Dai and Jingpo autonomous prefecture, Yunnan province].
    Tang RH; Ye RH; Yang YC; Yao ST; Wang JB; Zhang RM; Luo LF; Wu ZL; Long YC; Yin MS; He N; Duan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):336-340. PubMed ID: 28329935
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.
    Zhou W; Wang X; Zhou S; Xie N; Liu P; Luo L; Peng J; Liu M; Desrosiers A; Schottenfeld R; Chawarski MC
    Addiction; 2015 May; 110(5):796-802. PubMed ID: 25529103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
    Zhuang X; Liang Y; Chow EP; Wang Y; Wilson DP; Zhang L
    BMC Infect Dis; 2012 Jun; 12():130. PubMed ID: 22682091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.